Previous 10 | Next 10 |
home / stock / brsyf / brsyf news
BrainsWay Ltd. (BWAY) Q1 2021 Earnings Conference Call May 20, 2021 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Chris von Jako - President & Chief Executive Officer Scott Areglado - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jeffre...
BrainsWay Ltd. (BWAY) Q4 2020 Earnings Conference Call March 25, 2021 8:30 AM ET Company Participants Chase Oswald – LifeSci Advisors Christopher von Jako – President and Chief Executive Officer Hadar Levy – Senior Vice President and General Manager-North America and Inte...
FDA clearance for smoking cessation moves Brainsway towards a portfolio of neurological disorder treatments and extends the company’s competitive advantage. The publication of positive real-world results for treating OCD adds support to the case for insurance reimbursement, alt...
Brainsway Ltd. (BWAY) Q3 2020 Earnings Conference Call November 18, 2020 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Chris von Jako - President & Chief Executive Officer Judy Huber - Chief Financial Officer Conference Call Participants Steven Lichtman...
BrainsWay Ltd. (BWAY) Q2 2020 Earnings Conference Call August 12, 2020 08:30 ET Company Participants Bob Yedid - LifeSci Advisors, Investor Relations Christopher von Jako - President & Chief Executive Officer Judy Huber - Chief Financial Officer Conference Call Participant...
BrainsWay Ltd. (BWAY) Q1 2020 Earnings Conference Call June 24, 2020, 08:30 AM ET Company Participants Bob Yedid - MD, LifeSci Advisors, IR Christopher von Jako - President and CEO Judy Huber - Chief Financial Officer Conference Call Participants Jayson Bedford - Raymond J...
Brainsway Ltd. (BWAY) Q4 2019 Earnings Conference Call March 23, 2020 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Christopher von Jako - CEO Hadar Levy - COO and CFO Conference Call Participants Craig Bijou - Cantor Fitzgerald Jayson Bedford - Raymond Ja...
Brainsway ( OTCPK:BRSYF ): Q4 Operating loss of $1.7M. More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
Neuronetics (STIM) recently released a solid quarterly report that included 30.94% revenue growth and a massive amount of cash. Almost 90% of its total amount of assets is represented by cash. The market did not seem to assess the figures reported and pushed the stock price down in November. A...
Brainsway ( OTCPK:BRSYF ) reports Q2 revenue growth of 54.2% Y/Y to $3.7M. More news on: Brainsway Ltd., Read more ...
News, Short Squeeze, Breakout and More Instantly...
BURLINGTON, Mass. and JERUSALEM, July 23, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will rep...
BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its broad market...
BURLINGTON, Mass. and JERUSALEM, June 10, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the initiation o...